Literature DB >> 23011743

Novel antihypertensive therapies: renal sympathetic nerve ablation and carotid baroreceptor stimulation.

Guido Grassi1, Gino Seravalle, Gianmaria Brambilla, Michele Bombelli, Raffaella Dell'Oro, Edoardo Gronda, Giuseppe Mancia.   

Abstract

Therapeutic interventions aimed at reducing high blood pressure still encompass a number of difficulties and limitations. This is the case particularly in resistant hypertension, i.e. a condition characterized by a very high cardiovascular risk. Carotid baroreceptor stimulation and renal sympathetic nerves ablation represent new approaches in the treatment of this condition. This paper will provide a comparison of the effects of the two procedures, highlighting their effects on blood pressure, metabolic profile, target organ damage, safety and tolerability profile.

Entities:  

Mesh：

Year:  2012        PMID： 23011743     DOI： 10.1007/s11906-012-0312-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  27 in total

Review 1.  Blood pressure control and antihypertensive treatment.

Authors:  Guido Grassi; Gino Seravalle; Fosca Quarti Trevano; Raffaella Dell'Oro; Giuseppe Mancia
Journal:  Curr Vasc Pharmacol       Date:  2012-07       Impact factor: 2.719

2.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

3.  Low-dose spironolactone in the management of resistant hypertension: a surveillance study.

Authors:  Deirdre A Lane; Sarah Shah; D Gareth Beevers
Journal:  J Hypertens       Date:  2007-04       Impact factor: 4.844

4.  Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

Authors:  Markus P Schlaich; Nora Straznicky; Mariee Grima; Carolina Ika-Sari; Tye Dawood; Felix Mahfoud; Elisabeth Lambert; Reena Chopra; Flora Socratous; Sarah Hennebry; Nina Eikelis; Michael Böhm; Henry Krum; Gavin Lambert; Murray D Esler; Paul A Sobotka
Journal:  J Hypertens       Date:  2011-05       Impact factor: 4.844

5.  ESH position paper: renal denervation - an interventional therapy of resistant hypertension.

Authors:  Roland E Schmieder; Josep Redon; Guido Grassi; Sverre E Kjeldsen; Giuseppe Mancia; Krzysztof Narkiewicz; Gianfranco Parati; Luis Ruilope; Philippe van de Borne; Costas Tsioufis
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

6.  Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.

Authors:  Jan Václavík; Richard Sedlák; Martin Plachy; Karel Navrátil; Jirí Plásek; Jirí Jarkovsky; Tomás Václavík; Roman Husár; Eva Kociánová; Milos Táborsky
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

7.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

8.  Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.

Authors:  Neil Chapman; Choon Lan Chang; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

Review 9.  Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.

Authors:  Guido Grassi
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  2 in total

Review 1.  Role of ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Guido Grassi; Michele Bombelli; Gino Seravalle; Gianmaria Brambilla; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 2.  The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.

Authors:  Lucilia N Diogo; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.